Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2005 Apr;4(4):572-7.
Epub 2005 Apr 16.

CAK-Cyclin-dependent Activating Kinase: A Key Kinase in Cell Cycle Control and a Target for Drugs?

Affiliations
  • PMID: 15876871
Review

CAK-Cyclin-dependent Activating Kinase: A Key Kinase in Cell Cycle Control and a Target for Drugs?

Graziano Lolli et al. Cell Cycle. .

Abstract

The Cyclin-dependent kinase (CDK) Activating Kinase (CAK) is responsible for the activating phosphorylation of CDK1, CDK2, CDK4 and CDK6 and regulation of the cell cycle. The kinase is composed of three subunits: CDK7, Cyclin H and MAT1 (ménage a trois). Together with six other subunits, CAK is also part of the general transcription factor TFIIH where it is involved in promoter clearance and progression of transcription from the preinitiation to the initiation stage. CAK is required for cell cycle progression, which suggests that CDK7 could be a target for cancer therapy. However its role in transcription and its ubiquitous presence raise sensible concerns about possible toxicity of its inhibitors. The recently determined structure of CDK7 allows the design of inhibitors with differential specificity for the different CDKs. We review the role of CAK in different biological processes and evaluate the biological evidence for CDK7 as a possible pharmacological target.

Similar articles

See all similar articles

Cited by 48 articles

See all "Cited by" articles

Publication types

Substances

LinkOut - more resources

Feedback